BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 11159527)

  • 21. Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome.
    Renjifo B; Chou K; Soto Ramirez L; Garcia Vallejo F; Essex M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996; 13 Suppl 1():S146-53. PubMed ID: 8797717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human T cell lymphotropic virus type I (HTLV-I) p12I is dispensable for HTLV-I transmission and maintenance of infection in vivo.
    Furukawa Y; Usuku K; Izumo S; Osame M
    AIDS Res Hum Retroviruses; 2004 Oct; 20(10):1092-9. PubMed ID: 15585100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activated, HTLV-1-specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis.
    Parker CE; Daenke S; Nightingale S; Bangham CR
    Virology; 1992 Jun; 188(2):628-36. PubMed ID: 1374983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating mRNA expression of tax, B chain of PDGF and PDGF-β receptors as well as HTLV-I proviral load in ATL patients and healthy carriers.
    Atabati H; Esmaeili SA; Allahyari A; Shirdel A; Rahimi H; Rezaee SA; Momtazi-Borojeni AA; Rafatpanah H
    J Med Virol; 2021 Jun; 93(6):3865-3870. PubMed ID: 32918495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
    Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degenerate specificity of HTLV-1-specific CD8+ T cells during viral replication in patients with HTLV-1-associated myelopathy (HAM/TSP).
    Kubota R; Furukawa Y; Izumo S; Usuku K; Osame M
    Blood; 2003 Apr; 101(8):3074-81. PubMed ID: 12480698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of recall response to Tax in ATL and HAM/TSP patients but not in asymptomatic carriers of human T-cell leukemia virus type 1.
    Manuel SL; Sehgal M; Connolly J; Makedonas G; Khan ZK; Gardner J; Betts MR; Jain P
    J Clin Immunol; 2013 Oct; 33(7):1223-39. PubMed ID: 23888327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-tumor immunity in adult T-cell leukemia].
    Kannagi M
    Uirusu; 2004 Jun; 54(1):67-74. PubMed ID: 15449906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
    Nosaka K; Matsuoka M
    Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells.
    Kannagi M; Harada S; Maruyama I; Inoko H; Igarashi H; Kuwashima G; Sato S; Morita M; Kidokoro M; Sugimoto M
    Int Immunol; 1991 Aug; 3(8):761-7. PubMed ID: 1911545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
    Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
    J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-Tax antibody levels in asymptomatic carriers, oligosymptomatic carriers, patients with rheumatologic disease or with HAM/TSP do not correlate with HTLV-1 proviral load.
    de Souza JG; da Fonseca FG; Martins ML; Martins CP; de Carvalho LD; Coelho-dos-Reis JG; Carneiro-Proietti AB; Martins-Filho OA; Barbosa-Stancioli EF;
    J Clin Virol; 2011 Jan; 50(1):13-8. PubMed ID: 20951636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of MHC class I restricted cytotoxic T cell responses to tax in HTLV-1 infected patients with neurologic disease.
    Koenig S; Woods RM; Brewah YA; Newell AJ; Jones GM; Boone E; Adelsberger JW; Baseler MW; Robinson SM; Jacobson S
    J Immunol; 1993 Oct; 151(7):3874-83. PubMed ID: 7690819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma.
    Arnulf B; Thorel M; Poirot Y; Tamouza R; Boulanger E; Jaccard A; Oksenhendler E; Hermine O; Pique C
    Leukemia; 2004 Jan; 18(1):126-32. PubMed ID: 14574331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients.
    Ramirez E; Fernandez J; Cartier L; Villota C; Rios M
    Virus Res; 2003 Feb; 91(2):231-9. PubMed ID: 12573502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
    Kannagi M; Hasegawa A; Nagano Y; Iino T; Okamura J; Suehiro Y
    Cancer Sci; 2019 Mar; 110(3):849-857. PubMed ID: 30666755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential immunogenicity of adult T cell leukemia cells in vivo.
    Kurihara K; Harashima N; Hanabuchi S; Masuda M; Utsunomiya A; Tanosaki R; Tomonaga M; Ohashi T; Hasegawa A; Masuda T; Okamura J; Tanaka Y; Kannagi M
    Int J Cancer; 2005 Mar; 114(2):257-67. PubMed ID: 15551352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
    Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
    Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.
    Haynes RA; Phipps AJ; Yamamoto B; Green P; Lairmore MD
    Viral Immunol; 2009 Dec; 22(6):397-405. PubMed ID: 19951176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of IL-21 in HTLV-1 infections with emphasis on HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Rajaei T; Farajifard H; Rafatpanah H; Bustani R; Valizadeh N; Rajaei B; Rezaee SA
    Med Microbiol Immunol; 2017 Jun; 206(3):195-201. PubMed ID: 28378248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.